Immunome, Inc. (IMNM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1232841,
    "name": "Immunome, Inc.",
    "stock_name": "Immunome, Inc.",
    "full_name": "Immunome, Inc.",
    "name_url": "stocks-analysis/immunome-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "20.09",
    "chg": 3,
    "chgp": "17.55%",
    "dir": 1,
    "prev_price": "17.09",
    "mcapval": "818.22",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US45257U1088",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "3.07 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/immunome-inc-1232841-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Immunome Stock Hits Day Low of $14.71 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/immunome-stock-hits-day-low-of-1471-amid-price-pressure-3676135",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ImmunomeInc_priceRelatedfactors_3676135.png",
        "date": "2025-11-06 16:15:24",
        "description": "Immunome, Inc. faced a significant stock decline today, reaching an intraday low. Despite recent challenges, the company reported a higher net profit for the first half of the year and reduced raw material costs. Its long-term performance remains strong, with substantial gains year-to-date and over three years."
      },
      {
        "title": "Immunome, Inc. Hits New 52-Week High of $17.87",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/immunome-inc-hits-new-52-week-high-of-1787-3671495",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ImmunomeInc_priceRelatedfactors_3671495.png",
        "date": "2025-11-04 17:54:17",
        "description": "Immunome, Inc. has achieved a new 52-week high, reflecting a significant upward trend from its previous low. Despite underperforming compared to the S&P 500, the company's recent stock movement suggests a positive shift in market sentiment. Financial metrics indicate ongoing challenges, including losses and a negative debt-equity ratio."
      },
      {
        "title": "Immunome, Inc. Hits New 52-Week High at USD 17.32",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/immunome-inc-hits-new-52-week-high-at-usd-1732-3641259",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ImmunomeInc_priceRelatedfactors_3641259.png",
        "date": "2025-10-23 17:06:49",
        "description": "Immunome, Inc. has achieved a new 52-week high of USD 17.32, significantly up from its low of USD 5.15. With a market capitalization of approximately USD 818 million, the company faces challenges, including a negative return on equity and no dividend offerings, as it competes in the biotechnology sector."
      },
      {
        "title": "Immunome, Inc. Hits Day High with 15.96% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/immunome-inc-hits-day-high-with-1596-surge-in-stock-price-3626728",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ImmunomeInc_priceRelatedfactors_3626728.png",
        "date": "2025-10-16 19:00:15",
        "description": "Immunome, Inc. has seen notable stock activity, achieving a significant increase today and over the past week. The company reported a net profit turnaround after previous losses and has high institutional holdings. Its return on capital employed has improved, alongside a decrease in raw material costs, showcasing resilience in the market."
      },
      {
        "title": "Immunome, Inc. Hits New 52-Week High at $16.40",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/immunome-inc-hits-new-52-week-high-at-1640-3626623",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ImmunomeInc_priceRelatedfactors_3626623.png",
        "date": "2025-10-16 18:18:23",
        "description": "Immunome, Inc. has achieved a new 52-week high of USD 16.40, significantly up from its low of USD 5.15. With a market capitalization of USD 818 million, the company remains loss-making and does not pay dividends, indicating ongoing challenges in the biotechnology sector despite recent stock performance improvements."
      },
      {
        "title": "Immunome, Inc. Hits Day High with 16.4% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/immunome-inc-hits-day-high-with-164-surge-in-stock-price-3601750",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ImmunomeInc_priceRelatedfactors_3601750.png",
        "date": "2025-10-07 22:25:56",
        "description": "Immunome, Inc. has shown notable stock performance, gaining 16.4% on October 6, 2025, and achieving significant increases over the past week and month. Despite reporting a net profit loss for the first half of the year, the company benefits from high institutional holdings and reduced raw material costs."
      },
      {
        "title": "Immunome, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/immunome-inc-technical-trend-shifts-from-mildly-bullish-to-bullish-amid-strong-performance-3601270",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ImmunomeInc_technicaldot_3601270.png",
        "date": "2025-10-07 20:37:38",
        "description": "Immunome, Inc. has experienced notable stock price movement, closing at $14.41 after a year marked by significant volatility, with a 52-week high of $15.12 and a low of $5.15. The company has outperformed the S&P 500 across multiple time frames, showcasing its competitive positioning in the market."
      },
      {
        "title": "Is Immunome, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-immunome-inc-technically-bullish-or-bearish-3599084",
        "imagepath": "",
        "date": "2025-10-07 12:18:05",
        "description": "As of 3 October 2025, the technical trend for Immunome, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands indicate a bullish stance. Daily moving averages also support a bullish outlook. However, the monthly KST is bearish, and the Dow Theory shows a mildly bullish position on both weekly and monthly time frames. \n\nImmunome has outperformed the S&P 500 significantly over the past week (27.07% vs. 1.09%) and month (36.98% vs. 4.15%), while the year-to-date return of 35.69% also surpasses the S&P 500's 14.18%. Overall, the current technical stance is bullish with strong momentum indicators...."
      },
      {
        "title": "Immunome, Inc. Hits Day High with Strong 7.93% Intraday Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/immunome-inc-hits-day-high-with-strong-793-intraday-surge-3595717",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ImmunomeInc_priceRelatedfactors_3595717.png",
        "date": "2025-10-06 18:07:59",
        "description": "Immunome, Inc. has seen a significant rise in its stock today, contrasting with the S&P 500's minimal gain. The company reported a net profit after several quarters of losses and a decrease in raw material costs. Despite challenges over the past year, institutional holdings remain strong."
      }
    ],
    "total": 24,
    "sid": "1232841",
    "stock_news_url": "https://www.marketsmojo.com/news/immunome-inc-1232841"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Immunome Stock Hits Day Low of $14.71 Amid Price Pressure

2025-11-06 16:15:24

Immunome, Inc. faced a significant stock decline today, reaching an intraday low. Despite recent challenges, the company reported a higher net profit for the first half of the year and reduced raw material costs. Its long-term performance remains strong, with substantial gains year-to-date and over three years.

Immunome, Inc. Hits New 52-Week High of $17.87

2025-11-04 17:54:17

Immunome, Inc. has achieved a new 52-week high, reflecting a significant upward trend from its previous low. Despite underperforming compared to the S&P 500, the company's recent stock movement suggests a positive shift in market sentiment. Financial metrics indicate ongoing challenges, including losses and a negative debt-equity ratio.

Immunome, Inc. Hits New 52-Week High at USD 17.32

2025-10-23 17:06:49

Immunome, Inc. has achieved a new 52-week high of USD 17.32, significantly up from its low of USD 5.15. With a market capitalization of approximately USD 818 million, the company faces challenges, including a negative return on equity and no dividend offerings, as it competes in the biotechnology sector.

Immunome, Inc. Hits Day High with 15.96% Surge in Stock Price

2025-10-16 19:00:15

Immunome, Inc. has seen notable stock activity, achieving a significant increase today and over the past week. The company reported a net profit turnaround after previous losses and has high institutional holdings. Its return on capital employed has improved, alongside a decrease in raw material costs, showcasing resilience in the market.

Immunome, Inc. Hits New 52-Week High at $16.40

2025-10-16 18:18:23

Immunome, Inc. has achieved a new 52-week high of USD 16.40, significantly up from its low of USD 5.15. With a market capitalization of USD 818 million, the company remains loss-making and does not pay dividends, indicating ongoing challenges in the biotechnology sector despite recent stock performance improvements.

Immunome, Inc. Hits Day High with 16.4% Surge in Stock Price

2025-10-07 22:25:56

Immunome, Inc. has shown notable stock performance, gaining 16.4% on October 6, 2025, and achieving significant increases over the past week and month. Despite reporting a net profit loss for the first half of the year, the company benefits from high institutional holdings and reduced raw material costs.

Immunome, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance

2025-10-07 20:37:38

Immunome, Inc. has experienced notable stock price movement, closing at $14.41 after a year marked by significant volatility, with a 52-week high of $15.12 and a low of $5.15. The company has outperformed the S&P 500 across multiple time frames, showcasing its competitive positioning in the market.

Is Immunome, Inc. technically bullish or bearish?

2025-10-07 12:18:05

As of 3 October 2025, the technical trend for Immunome, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands indicate a bullish stance. Daily moving averages also support a bullish outlook. However, the monthly KST is bearish, and the Dow Theory shows a mildly bullish position on both weekly and monthly time frames. Immunome has outperformed the S&P 500 significantly over the past week (27.07% vs. 1.09%) and month (36.98% vs. 4.15%), while the year-to-date return of 35.69% also surpasses the S&P 500's 14.18%. Overall, the current technical stance is bullish with strong momentum indicators....

Immunome, Inc. Hits Day High with Strong 7.93% Intraday Surge

2025-10-06 18:07:59

Immunome, Inc. has seen a significant rise in its stock today, contrasting with the S&P 500's minimal gain. The company reported a net profit after several quarters of losses and a decrease in raw material costs. Despite challenges over the past year, institutional holdings remain strong.

View All News